Search for: "Eli Lilly " Results 421 - 440 of 2,147
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Sep 2017, 3:29 am
  Further, there was no indirect infringement - the SmPC of the generic product indicated that reconstitution and dilution would happen in a glucose solution, rather than a saline solution as specified in the claims of EP '508.Consideration of UK decision Eli Lilly drew the recent decision of the UK Supreme Court in Eli Lilly v Actavis to the Court of Milan's attention. [read post]
12 Sep 2017, 7:28 am by Robert Kraft
STAT reports on the “irony” in a ruling by a federal appeals court that Eli Lilly shouldn’t have stopped disability benefits for a former human resources executive with fibromyalgia when the company was marketing Cymbalta for the same condition. [read post]
12 Sep 2017, 4:00 am by Andrew Lavoott Bluestone
The doctrine of collateral estoppel has two requirements: (1) “the identical issue necessarily must have been decided in the prior action and be decisive of the present action,” and (2) “the party to be precluded from relitigating the issue must have had a full and fair opportunity to contest the prior determination” (Kaufman v Eli Lilly & Co., 65 NY2d 449, 455 [1985]; see Ackman v Haberer, 111 AD3d 1378, 1379 [2013]). [read post]
5 Sep 2017, 2:30 pm by Brenda Fulmer
Recently, Judge Seeborg expanded the MDL proceedings to include claims against Eli Lilly & Company, after patients who ingested Cialis (a drug similar to Viagra) also developed melanoma. [read post]
31 Aug 2017, 9:53 am
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle? [read post]
24 Aug 2017, 6:45 am by Tom Lamb
In June 2006 Health Canada issued a Public Communication alerting Canadians that the drug companies Eli Lilly (Cialis), Bayer (Levitra), and Pfizer (Viagra) were in the process of sending a so-called "Dear Doctor" letter to inform healthcare providers in Canada about changes to the respective package insert, or label, for these drugs regarding this vision loss, or NAION, side effect. [read post]
20 Aug 2017, 9:00 pm by Laurent Teyssèdre
Actavis avait saisi les juridictions britanniques en déclaration de non contrefaçon au Royaume Uni, en France, en Italie et en Espagne, du brevet EP1313508 détenu par Eli Lilly. [read post]
18 Aug 2017, 5:56 am
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle? [read post]
10 Aug 2017, 3:41 pm
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle? [read post]
10 Aug 2017, 9:43 am
Having been distracted from the world of IP by his daughter's recent wedding, there has been some delay in this GuestKat's posting of the third instalment of his commentary on Eli Lilly v Actavis UK, [2017] UKSC 48. [read post]
9 Aug 2017, 3:08 am by Liz Dunshee
The signatories to the principles include Aetna, American Express, Bank of America, Chevron, Eli Lilly, Fannie Mae, FICO, Goldman Sachs, Home Depot, Honeywell, JP Morgan, Microsoft, State Street & lots of other big names. [read post]
8 Aug 2017, 12:10 pm
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle? [read post]
25 Jul 2017, 5:34 am
UNCT/14/2 Eli Lilly & Co. v Government of Canada, (16 March 2017) ICSID At 10:00 on 17 Aug 2017 I shall give a talk to the IP Summer School at Cambridge entitled Bilateral Investment Treaties & Exporters' Rights Post-Brexit. [read post]
21 Jul 2017, 3:14 am
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle. [read post]